Holme J A, Trygg B, Søderlund E
Cancer Res. 1986 Apr;46(4 Pt 1):1627-32.
Monolayers of hepatocytes from mouse, hamster, rat, and guinea pig metabolized 2-acetylaminofluorene (AAF) to ether-extractable, water-soluble as well as covalently macromolecular bound products. Hamster hepatocytes showed the highest rate of formation of ether-extractable metabolites, rat and guinea pig the lowest. These species differences reflected mainly differences in the formation of 2-aminofluorene, the dominating ether-extractable metabolite formed. Detectable levels of N-hydroxy-AAF (greater than 1 nmol/10(6) cells) were only obtained with hamster hepatocytes. The major C-hydroxylated metabolites in the species tested were 7- and 9-hydroxy-AAF. Hepatocytes from guinea pig and hamster showed the highest rate of formation of C-hydroxylated and water-soluble metabolites, rat hepatocytes the lowest. The highest rate of covalent macromolecular binding by AAF metabolites was found with hamster hepatocytes, followed by hepatocytes from rat, guinea pig, and mouse. The balance between activation and detoxification reactions of AAF in hepatocytes may be expressed as the ratio between covalently bound metabolites and the sum of C-hydroxylated and stable water-soluble metabolites. This ratio was far greater in rat hepatocytes followed by hamster, guinea pig, and mouse, and it correlated better with the species susceptibility to liver cancer than covalent binding as such. Thus, AAF-induced liver cancer may depend more on the relative degree of activation versus detoxification of the administered dose than on the absolute capacity of the liver to activate the carcinogen.
来自小鼠、仓鼠、大鼠和豚鼠的单层肝细胞将2-乙酰氨基芴(AAF)代谢为可醚提取的水溶性产物以及共价大分子结合产物。仓鼠肝细胞形成可醚提取代谢物的速率最高,大鼠和豚鼠肝细胞的速率最低。这些物种差异主要反映在2-氨基芴的形成上,2-氨基芴是形成的主要可醚提取代谢物。仅在仓鼠肝细胞中检测到可检测水平的N-羟基-AAF(大于1 nmol/10⁶个细胞)。在所测试的物种中,主要的C-羟基化代谢物是7-和9-羟基-AAF。豚鼠和仓鼠的肝细胞形成C-羟基化和水溶性代谢物的速率最高,大鼠肝细胞的速率最低。AAF代谢物与共价大分子结合的最高速率在仓鼠肝细胞中发现,其次是大鼠、豚鼠和小鼠的肝细胞。AAF在肝细胞中的活化和解毒反应之间的平衡可以表示为共价结合代谢物与C-羟基化和稳定水溶性代谢物总和的比率。该比率在大鼠肝细胞中远高于仓鼠、豚鼠和小鼠,并且与物种对肝癌的易感性相关性比共价结合本身更好。因此,AAF诱导的肝癌可能更多地取决于给药剂量的活化与解毒的相对程度,而不是肝脏激活致癌物的绝对能力。